Cunillera-Puértolas, Oriol
Vizcaya, David
Cerain-Herrero, M. Jesús
Gil-Terrón, Neus
Cobo-Guerrero, Silvia
Salvador-González, Betlem
Funding for this research was provided by:
Pharmaceuticals Bayer
Article History
Received: 25 June 2021
Revised: 7 September 2022
Accepted: 6 October 2022
First Online: 23 November 2022
Declarations
:
: Ethical approval was obtained from the Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAPJGol) Clinical Research Ethics Committee (19/082-P). We did not seek informed consent from participants, as it was not deemed necessary by the research ethics committee. The Information System for Research in Primary Care (SIDIAP), hosted by the Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAPJGol), provided the data only once the protocol was aproved by its Scientific Committe and the IDIAPJGol Clinical Research Ethics Committee. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: DV works for Bayer Pharmaceuticals. The other authors declare no conflicts of interest.